Curry International Tuberculosis Center (CITC)
banner
citc-tb.bsky.social
Curry International Tuberculosis Center (CITC)
@citc-tb.bsky.social
CITC @UCSF creates, enhances, and disseminates state-of-the-art resources and models of excellence to control and eliminate TB in the U.S. and Internationally

#Tuberculosis
Format: Hybrid – self-paced online modules + one live interactive session

Self-paced Module Dates: Now until December 12, 2025
Credit: This training is approved for up to 6.5 Continuing Education (CE) hours.

Cost: All CITC trainings are free of charge.
October 22, 2025 at 4:38 PM
Target Audience: Nurses and public health/disease control investigators who are new to TB prevention and care responsibilities. Content covers the foundational concepts necessary for staff to conduct contact investigations and case management for persons with LTBI.
October 22, 2025 at 4:38 PM
This Level 1: TB Basics, Contact Investigation & LTBI training includes 5 online self-paced modules, and 1 live interactive session. This online, asynchronous training for nurses & public health/disease control investigators can be accessed, started, and revisited at any time during the course term
October 22, 2025 at 4:38 PM
This webinar will discuss key laboratory tests used in the diagnosis and management of TB disease. Participants will gain practical insights into interpreting lab results and understanding their clinical implications.
October 21, 2025 at 11:17 PM
Please visit our website for ongoing conference program updates as we finalize our agenda over the next few months.We look forward to seeing to both new and familiar faces in support of the North American TB community."
September 26, 2025 at 11:17 PM
"The 2026 End TB Conference of the Union North American Region is looking forward to holding its 30th annual conference at the Westin Philadelphia Hotel. We hope that you will join us in person to participate in our pre-conference postgraduate sessions and stay to attend our full conference.
September 26, 2025 at 11:17 PM
This also provides information on the potential benefits and risks of TB preventive therapy.
September 15, 2025 at 8:14 PM
This decision aid provides information about the likelihood of developing TB disease, dying from TB, as well as post TB disability, in the next 20 years in a person with a positive Tuberculin skin test or a positive Interferon gamma release assay and a known risk factor.
September 15, 2025 at 8:14 PM